He has a PhD in Literature from the University of New Mexico and is the recipient many awards, including a 1986 NEA Literary Fellowship, the 1987 Vogelstein Foundation Award, and the 1988 Pushcart Prize
Key findings included: Excellent tolerability with less than 10% reporting any digestive discomfort Dose-dependent biological responses indicating successful butyrate generation Favorable shifts in markers such as hs-CRP Metabolic effects suggesting enhanced butyrate availability Confirmation that 200mg daily appears to be the optimal dose The ButyraGen Clinical Breakthrough (Dosz 2025) The second study focused on individuals seeking digestive comfort, providing even more compelling results
The relevance of further hormones and signaling peptides involved in energy homeostasis in taste cells has been elegantly summarized by recent reviews [1820121142]
Youll see a board-certified rheumatologist in days, not months, via telehealth across 20+ states with no referral required
GHK-Cu is a cosmetic formulation and is not intended to diagnose, treat, cure, or prevent any condition
